


Immune-engineered H7N9 influenza hemagglutinin improves protection against viral influenza virus challenge
Immune engineered H7N9 influenza hemagglutinin improves protection against viral influenza virus challenge
Poster: Addressing Immunogenicity of Observed and Theoretical Impurities for Peptide Abbreviated New Drug Applications
Addressing Immunogenicity of Observed and Theoretical Impurities for Peptide Abbreviated New Drug Applications
T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020
2020 TCWP